Coherus BioSciences, Inc. (CHRS)

NASDAQ: CHRS · IEX Real-Time Price · USD

2.070

+0.070 (3.50%)

At close: Apr 19, 2024, 4:00 PM

2.060

-0.010 (-0.48%)

After-hours: Apr 19, 2024, 7:47 PM EDT

Coherus BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	257.24	211.04	326.55	475.82	356.07	0	1.56	190.11	30.04	31.11	Upgrade
Revenue Growth (YoY)	21.89%	-35.37%	-31.37%	33.63%	-	-	-99.18%	532.82%	-3.42%	1030.72%	Upgrade
Cost of Revenue	158.99	70.08	57.59	37.67	17.08	0	0	0	0	0	Upgrade
Gross Profit	98.25	140.96	268.96	438.16	338.99	0	1.56	190.11	30.04	31.11	Upgrade
Selling, General & Admin	192.02	198.48	169.71	139.08	137.04	94.18	71.3	51.6	36.05	17.56	Upgrade
Research & Development	109.44	199.36	363.11	142.76	94.19	110.24	162.39	254.44	213.06	78.22	Upgrade
Operating Expenses	301.45	397.84	532.82	281.84	231.23	204.42	233.69	306.04	249.11	95.79	Upgrade
Operating Income	-203.2	-256.88	-263.86	156.32	107.77	-204.42	-232.14	-115.93	-219.07	-64.68	Upgrade
Interest Expense / Income	40.54	32.47	22.96	21.17	17.6	9.68	9.55	7.98	0.03	3.9	Upgrade
Other Expense / Income	-5.47	2.4	0.28	-0.55	-2.61	-4.76	-3.52	3.43	4.16	18.55	Upgrade
Pretax Income	-238.27	-291.75	-287.1	135.71	92.78	-209.34	-238.17	-127.34	-223.26	-87.13	Upgrade
Income Tax	-0.38	0	0	3.46	2.94	0	0	0	0	0	Upgrade
Net Income	-237.89	-291.75	-287.1	132.24	89.83	-209.34	-238.17	-127.34	-223.26	-87.13	Upgrade
Net Income Growth	-	-	-	47.21%	-	-	-	-	-	-	Upgrade
Shares Outstanding (Basic)	94	78	75	71	70	65	53	42	37	8	Upgrade
Shares Outstanding (Diluted)	94	78	75	71	73	65	53	42	37	8	Upgrade
Shares Change	21.30%	2.89%	5.65%	-2.42%	12.53%	22.40%	26.77%	12.90%	353.45%	145.69%	Upgrade
EPS (Basic)	-2.53	-3.76	-3.81	1.85	1.29	-3.22	-4.48	-3.04	-6.01	-10.64	Upgrade
EPS (Diluted)	-2.53	-3.76	-3.81	1.62	1.23	-3.22	-4.48	-3.04	-6.01	-10.64	Upgrade
EPS Growth	-	-	-	31.71%	-	-	-	-	-	-	Upgrade
Free Cash Flow	-174.33	-243.16	-38.72	147.09	26.53	-160.06	-204.86	-259.06	-114.15	-26.78	Upgrade
Free Cash Flow Per Share	-1.85	-3.13	-0.51	2.06	0.38	-2.46	-3.86	-6.18	-3.08	-3.27	Upgrade
Gross Margin	38.19%	66.79%	82.36%	92.08%	95.20%	-	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-78.99%	-121.72%	-80.80%	32.85%	30.27%	-	-14918.77%	-60.98%	-729.23%	-207.94%	Upgrade
Profit Margin	-92.48%	-138.24%	-87.92%	27.79%	25.23%	-	-15306.56%	-66.98%	-743.18%	-280.12%	Upgrade
Free Cash Flow Margin	-67.77%	-115.22%	-11.86%	30.91%	7.45%	-	-13165.75%	-136.27%	-379.99%	-86.08%	Upgrade
Effective Tax Rate	-	-	-	2.55%	3.17%	-	-	-	-	-	Upgrade
EBITDA	-191.46	-253.08	-258.48	159.76	115.42	-196.42	-225.22	-116.36	-221.36	-82.56	Upgrade
EBITDA Margin	-74.43%	-119.92%	-79.15%	33.58%	32.42%	-	-14474.29%	-61.21%	-736.85%	-265.41%	Upgrade
Depreciation & Amortization	6.27	6.2	5.66	2.89	5.05	3.24	3.4	3	1.87	0.67	Upgrade
EBIT	-197.73	-259.28	-264.14	156.87	110.38	-199.66	-228.62	-119.36	-223.23	-83.23	Upgrade
EBIT Margin	-76.86%	-122.86%	-80.89%	32.97%	31.00%	-	-14692.67%	-62.78%	-743.07%	-267.58%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).